AGREEMENT AND PLAN OF MERGER BY AND AMONG INNOVUS PHARMACEUTICALS, INC., INNOVUS PHARMA ACQUISITION CORPORATION, INNOVUS PHARMA ACQUISITION CORPORATION II, NOVALERE FP, INC., AND NOVALERE HOLDINGS, LLC DATED AS OF FEBRUARY 4, 2015Agreement and Plan of Merger • February 5th, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 5th, 2015 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made as of February 4, 2015 (the “Agreement Date”), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation (“Acquiror”), Innovus Pharma Acquisition Corporation, a Delaware corporation (“Merger Sub One”) and a wholly owned subsidiary of Acquiror, Innovus Pharma Acquisition Corporation II, a Delaware corporation (“Merger Sub Two”) and a wholly owned subsidiary of Acquiror, Novalere FP, Inc., a Delaware corporation (“Target”), and Novalere Holdings, LLC, a Delaware limited liability company, as a representative of the stockholders of Target (“Holdings” or the “Stockholder Representative”).
VOTING AGREEMENTVoting Agreement • February 5th, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 5th, 2015 Company Industry JurisdictionTHIS VOTING AGREEMENT (this “Agreement”), is made as of the 4th day of February, 2015, by and among Innovus Pharmaceuticals, Inc., Nevada corporation (the “Company”), Novalere Holdings, LLC, a Delaware limited liability company (the “Stockholder”), and any transferees who become parties to this Agreement as “Stockholders” in accordance with Subsection 5(a) hereof.
REGISTRATION RIGHTS AND STOCK RESTRICTION AGREEMENTRegistration Rights and Stock Restriction Agreement • February 5th, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 5th, 2015 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AND STOCK RESTRICTION AGREEMENT (this “Agreement”), is made as of the 4th day of February, 2015, by and among Innovus Pharmaceuticals, Inc., Nevada corporation ( “Acquiror”), Novalere Holdings, LLC, a Delaware limited liability company (“Stockholder”), and any transferees who become parties hereto as “Holders” in accordance with Subsection 4.1 below.